Multidisciplinary Evaluation denied due to quantity / dose limits by Humana?

Humana's specific coverage criteria for multidisciplinary evaluation are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Applies Quantity Limits to Multidisciplinary Evaluations — and How to Appeal

When Humana limits the number of multidisciplinary evaluations it will cover in a given period, it is applying a utilization management tool that is not inherently unreasonable — but it becomes inappropriate when a patient's clinical situation genuinely requires more frequent coordinated specialist review than the plan's limit allows. Quantity limits on professional consultations must still be applied consistent with medical necessity standards; a blanket limit that overrides documented clinical need is appealable.

## The Federal Appeal Framework

• Internal appeal (Level 1): File a written appeal within Humana's deadline (typically 180 days from the denial notice). Humana must respond within 30 days for pre-service denials or 60 days for post-service claims.
• Expedited review: If the additional evaluation is urgently needed, request expedited review; Humana must respond within 72 hours.
• External review (ACA §2719): After a final internal denial, request independent external review — generally within 4 months of the adverse determination. An accredited IRO will determine whether the quantity limit, as applied to your specific case, is consistent with generally accepted standards of care.
• ERISA §503: For employer-sponsored plans, the denial must include a specific clinical rationale, not merely cite a blanket limit.

## Documents to Gather

1. Clinical justification for additional evaluations: Chart notes documenting why the patient's condition has changed, progressed, or become more complex since the prior authorized evaluation — establishing that the additional encounter is not duplicative but clinically distinct. 2. Specialist statements: Letters from each participating specialist explaining why their renewed input is medically necessary at this stage of treatment. 3. Prior evaluation records: Documentation of what was decided and recommended at previous multidisciplinary evaluations, and what has changed clinically that necessitates another one. 4. Prescribing or coordinating physician letter: An overarching medical-necessity letter tying together the clinical trajectory and explaining why the plan's quantity limit is insufficient for this patient's specific condition. 5. Relevant guideline reference: Ask your physician to note any applicable specialty society (e.g., NCCN, relevant clinical body) recommendation for evaluation frequency in this condition, without citing specific numeric thresholds.

## Criteria-Mapping Structure

In the appeal letter, directly address the quantity limit. Present the argument in three parts:

1. Policy compliance: Confirm how many evaluations have been used against the limit and that this request falls within what is being disputed. 2. Clinical distinction: Demonstrate that the requested evaluation addresses a new or progressed clinical question — not merely a repetition of prior consultations. 3. Medical necessity override: Argue that where a quantity limit conflicts with individually documented medical necessity, the medical necessity standard governs under Humana's own plan documents and applicable state law.

## Key Principle

Quantity limits in health plans are presumptive, not absolute. They may be exceeded when a treating physician documents that the patient's clinical circumstances require it. The appeal record should make clear that your physician is not requesting a routine follow-up but is responding to a specific, documented change in the patient's condition that requires coordinated specialist input beyond the plan's default limit.